Specialized Pharmaceutical Compositions for High-Risk Environments

This inventive concept adapts pharmaceutical compositions comprising substituted nucleotides and nucleosides for treating viral infections in high-security needs, disaster relief, extreme weather conditions, remote areas, and high-altitude environments.

The original patent disclosed nucleotide and nucleoside therapeutic compositions for treating viral infections. However, these compositions may not be suitable for high-risk environments, such as high-security facilities, disaster-stricken areas, extreme weather conditions, remote areas, and high-altitude environments, where specialized delivery devices, resistant excipients, and adapted formulations are required.

The new inventive concept comprises pharmaceutical compositions of Formula Im:, or a pharmaceutically acceptable salt or tautomer thereof, adapted for high-security needs, disaster relief, extreme weather conditions, remote areas, and high-altitude environments. The compositions may include security-enhanced delivery devices, excipients resistant to degradation under extreme weather conditions, and portable, solar-powered refrigeration units. The adapted formulations and delivery systems enable effective treatment of viral infections in these high-risk environments.

The new claims introduce novel adaptations of the original pharmaceutical compositions for treating viral infections, including specialized delivery devices, excipients, and formulations tailored to high-security needs, disaster relief, extreme weather conditions, remote areas, and high-altitude environments. These adaptations provide a non-obvious solution to the limitations of the original patent.

Alternative embodiments of the inventive concept may include varying the type of security-enhanced delivery device, using different excipients resistant to degradation under extreme weather conditions, or incorporating additional features into the portable, solar-powered refrigeration unit. Variations may also include adapting the pharmaceutical compositions for treating viral infections in other high-risk environments, such as confined spaces or areas with limited medical resources.

The specialized pharmaceutical compositions for high-risk environments have significant commercial potential in industries such as biotechnology, pharmaceuticals, and disaster relief. The target market includes government agencies, non-profit organizations, and private companies operating in high-security facilities, disaster-stricken areas, extreme weather conditions, remote areas, and high-altitude environments.